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Background: Protein/protein interactions are critical for signal transduction.
Results: Nucleotide-binding oligomerization domain-containing protein 1 (NOD1) helix 2 mutants impair signaling but not
interaction with receptor-interacting protein 2 (RIP2).
Conclusion: NOD1 and RIP2 interaction is necessary, but not sufficient, for NOD1 signaling.
Significance: NOD1 signaling is more complex than previously assumed and is likely to involve multiple CARD interfaces.
Following activation, the cytoplasmic pattern recognition
receptor nucleotide-binding oligomerization domain-contain-
ing protein 1 (NOD1) interacts with its adaptor protein recep-
tor-interacting protein 2 (RIP2) to propagate immune signaling
and initiate a proinflammatory immune response. This interac-
tion is mediated by the caspase recruitment domain (CARD) of
both proteins. Polymorphisms in immune proteins can affect
receptor function and predispose individuals to specific autoin-
flammatory disorders. In this report, we show that mutations in
helix 2 of the CARD of NOD1 disrupted receptor function but
did not interfere with RIP2 interaction. In particular, N43S, a
rare polymorphism, resulted in receptor dysfunction despite
retaining normal cellular localization, protein folding, and an abil-
ity to interact with RIP2. Mutation of Asn-43 resulted in an
increased tendency to formdimers,whichwepropose is the source
of this dysfunction.We also demonstrate thatmutation of Lys-443
and Tyr-474 in RIP2 disrupted the interaction with NOD1. Map-
ping the key residues involved in the interaction between NOD1
andRIP2to theknownstructuresofCARDcomplexes revealed the
likely involvement of both type I and type III interfaces in the
NOD1RIP2 complex. Overall we demonstrate that the NOD1-
RIP2 signaling axis ismore complex thanpreviously assumed, that
simpleengagementofRIP2 is insufficient tomediate signaling, and
that the interaction betweenNOD1 andRIP2 constitutesmultiple
CARD-CARD interfaces.
Nucleotide-binding leucine-rich repeat-containing (NLR)3
proteins are key components of the innate immune system.
Many NLRs serve as cytoplasmic sentinels responding to both
exogenous and endogenous danger signals. NLRs have a tripar-
tite domain organization with an N-terminal effector domain
required for signal transduction, a central nucleotide binding
domain reportedly involved in protein oligomerization, and a
C-terminal leucine-rich repeat domain essential for ligand
detection and receptor stimulation (1–4). Activation of NLR
family members can result in a proinflammatory immune
response and/or formation of an inflammasome and subse-
quent activation of caspase-1 (1).
The prototype NLR proteins, NOD1 and NOD2, are acti-
vated by the bacterial peptidoglycan fragments D-Glu-meso-di-
aminopimelic acid (iE-DAP) and muramyl dipeptide, respec-
tively. Activation of NOD1/2 results in receptor translocation
from the cytoplasm to the plasma membrane and precipitates
homotypic interactions between the effector CARDs of the
receptors and their adaptor protein RIP2 (also known as RICK)
(5–8). RIP2 is subsequently autophosphorylated at Tyr-474,
precipitating a series of ubiquitination events involving ubiqui-
tin ligases, such as X-linked inhibitor of apoptosis and the
cellular inhibitor of apoptosis proteins 1 and 2 (9–12). Defects
in NOD2, such as the Crohn disease-associated mutation
L1007fsincC, result in a loss of RIP2 autophosphorylation and a
lack of response to ligand stimulation (9). Signal transduction
via RIP2 leads to induction of the NFB pathway (13, 14).
NOD2 has also been shown to signal via CARD9 to activate the
p38 and c-Jun N-terminal kinase mitogen-activated protein
kinase pathways (15), to activate the non-canonical NFBpath-
way via engagement of NFB-inducing kinase (16), and to acti-
vate interferon-regulatory factor 3 following recognition of
viral single-stranded RNA (17).
The biological contribution of NOD1 and NOD2 to the
mammalian innate immune response has been well docu-
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mented. However, the precise structural and molecular details
of NOD1 and NOD2 activation remain largely elusive. Interac-
tions between the effector domains of NOD1 and RIP2 have
been studied by a number of groups (13, 14, 18, 19). These
studies have shown that an acidic patch on helix 3 of the NOD1
CARD forms the primary binding interface with basic residues
in RIP2 predicted to be located on the first and fourth helices
(18).
In this study, we used a combination of functional and bio-
chemical studies to thoroughly investigate the precise nature of
the interaction between the CARDs of NOD1 and RIP2. Muta-
tions in regions of helix 2 of the NOD1 CARD interfered with
signal transduction but did not affect interaction with RIP2 or
the cellular localization of NOD1. Studies with recombinant
proteins suggest that this functional impactmay be the result of
alterations in the propensity of the NOD1 CARD to self-asso-
ciate. Mutational analysis of the RIP2 CARD suggested that
Lys-443 and Tyr-474, a previously described site of autophos-
phorylation, may also be important for permitting interaction
withNOD1.Comparative analysiswith the structures of known
CARD-CARD interfaces indicates that the interaction between
NOD1 and RIP2 is likely to involve type I and type III, but not
type II, interfaces, thereby suggesting that formation of the
downstream signaling complexmay bemore complex than pre-
viously assumed.
EXPERIMENTAL PROCEDURES
Plasmids—pUNO-NOD1, encoding full-length untagged
NOD1, was a kind gift from Dr. P. Murray; pCMV-NOD1 pro-
duces full-length NOD1 with an N-terminal FLAG tag (20);
pCI-RIP2-Myc-His, pEF6-CARD9-V5, and GB1-RIP2-CARD
were kind gifts from Drs. K. Fitzgerald, D. Underhill, and K.
Rittinger, respectively; pLuc and phrG (Promega) encode firefly
and Renilla luciferase, respectively. The NOD1 CARD domain
(residues 15–110) was cloned into pDEST-HisMBP (21),
pGEX4T1, and pET28 vectors to enable expression of His-
maltose-binding protein (MBP), glutathione S-transferase
(GST), and His6-tagged protein. Site-directed mutagenesis was
used to generate mutant NOD1 constructs in pUNO, pCMV,
pET28, and pGEX4T1 backbones and mutant GB1-RIP2-
CARD constructs.
Luciferase Reporter and Co-immunoprecipitation Assays—
HEK293 cells were maintained in DMEM (Sigma) supple-
mented with 10% FCS, 100 g/ml penicillin/streptomycin, and
2 mM L-glutamine at 37 °C and 5% CO2. Cells were transfected
using jetPEI (Polyplus Transfection) with 0.1 ng/well NOD1
DNAand 1 ng/well pLuc and phrG in a 96-well plate. Cells were
stimulated with specified concentrations of either iE-DAP
(Invivogen) or the control ligand iE-Lys (Invivogen) concomi-
tantly with DNA transfection. Cells were lysed 24 h post-trans-
fection with 1 passive lysis buffer (Promega), and lumines-
cence measured with a LUMIstar Luminometer (BMG
Labtech). Protein expression was checked 24 h after transfec-
tion of HEK293 cells with 3 g of DNA/well in a 6-well plate
without ligand stimulation. NOD1 was visualized by Western
blot using the NOD1 monoclonal antibody 2A10 (6). For co-
immunoprecipitations, HEK293 cells were transfected with 1.5
g of both pCMV-NOD1 and pCI-RIP2-MycHis in the pres-
ence and absence of 100 ng/ml iE-DAP. After 24 h, cells were
washed twice in 1 PBS and lysed in 400 l of radioimmune
precipitation assay buffer (50 mM Tris-HCl, pH 7.6, 150 mM
NaCl, 0.25% Triton X-100, 0.1% SDS, 0.5% sodium deoxy-
cholate) supplemented with 1 Protease Inhibitor Mixture set
V (Calbiochem) and 125 units of Benzonase nuclease (Sigma)/
well. Lysates were incubated on ice for 10min with shaking and
clarified by centrifugation (16,000 g; 2 min; 20 °C). Superna-
tants were incubated with anti-FLAG antibody (Sigma; F3165)
immobilized onProteinG-coatedmagneticDynabeads (Invit-
rogen) according to the manufacturer’s protocol. Beads were
washed, and immunoprecipitated proteins were eluted under
denaturing conditions before detection by Western blotting
with the specified antibodies.
Immunofluorescence—HeLa cells were seeded on glass cov-
erslips and transiently transfected with 1 g of the expression
plasmids using FuGENE 6 transfection reagent (Roche Applied
Science) according to the manufacturer’s instructions. After
24 h, cells were fixed with 3% paraformaldehyde (Roth) in PBS
for 10min and permeabilized with 0.5% Triton X-100 (Roth) in
cold PBS for 5min. Cells were blocked in 3% BSA (Roth) in PBS
for 20 min and incubated successively in mouse anti-FLAGM2
(1:20,000; Stratagene) and goat anti-mouse Alexa Fluor 546 (1:
200; Invitrogen Molecular Probes) antibodies. DNA was
stainedwithDAPI (5g/ml; InvitrogenMolecular Probes), and
actin was stained with phalloidin-FITC (2.5 g/ml; Sigma-Al-
drich). Cells were mounted in ProLong Gold antifade reagent
(Invitrogen Molecular Probes). Image acquisition of z-stacks
was performed on an Olympus FV-1000 laser-scanning micro-
scope (objective, Olympus PlanApo, 60/1.40 oil, 8/0.17) and
processed using ImageJ software.
Subcellular Fractionation—Membrane and cytosolic frac-
tionation of transfected HEK293 cells was performed using a
Subcellular Fractionation kit (Pierce) according to the manu-
facturer’s instructions. Antibodies against Flotillin-2 (Abcam)
andGAPDH (Abcam)were used to characterize themembrane
and cytosolic fractions.
Expression of His-tagged Recombinant NOD1 CARD—Pro-
teins were expressed from pET28-NOD1 CARD(15–110) or
the respective mutant in Terrific broth overnight at 20 °C. Bac-
terial pellets were stored at20 °C, resuspended in lysis buffer
(25 mM sodium phosphate, pH 7.3, 300 mM NaCl, 20 mM imid-
azole, 0.1% Triton X-100 (v/v), 5 mM -mercaptoethanol, 1
mg/ml lysozyme, 250 units of Benzonase (Sigma), 1 Protease
Inhibitor Mixture set V), and lysed by sonication, and recom-
binant protein was recovered using nickel-nitrilotriacetic acid
affinity chromatography and size exclusion chromatography
(25 mM sodium phosphate, 100 mMNaCl,2mMDTT; Super-
dex 75 HiLoad 16/60 column, GE Healthcare).
GST Co-purification and Pulldown Assays—GST-NOD1-
CARD or His-MBP-NOD1-CARD and GB1-RIP2-CARD were
expressed in separate 50-ml Luria broth cultures overnight at
20 °Cusing 1mM isopropyl 1-thio--D-galactopyranoside. Cells
were harvested (8,000  g, 4 °C, 15 min), and bacterial pellets
were stored at 20 °C before resuspension in 0.5 ml of lysis
buffer supplemented with 50 units of Benzonase nuclease
(Sigma), 1mg/ml lysozyme, and 1 Protease InhibitorMixture
set V. Lysates were incubated with rotation for 5 min at room
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temperature and thenmixed as appropriate. Samples were son-
icated, clarified (4 °C, 16,000  g, 10 min), incubated with 150
l of glutathione-Sepharose 4B (GE Healthcare) (pre-equili-
brated in lysis buffer) for 30 min at 25 rpm at 4 °C, washed with
15 ml of lysis buffer, eluted in 300 l of elution buffer (50 mM
Tris, pH 8.0, 100 mM NaCl, 1 mM DTT, 50 mM reduced gluta-
thione), and analyzed by SDS-PAGE.
CircularDichroism—Proteinswere buffer-exchanged into 25
mM sodium phosphate, pH 7, 100 mM sodium fluoride, 1 mM
tris(2-carboxyethyl)phosphine (TCEP) and centrifuged (16,000
g, 10 min, 4 °C); and 400 l was loaded into a 1.0-mm quartz
cuvette. CD scans were performed using an Aviv model 4.0 CD
spectrophotometer. Machine units were converted to mean
residue ellipticity, [], using Dichroweb (22) and analyzed with
GraphPad Prism 4. Secondary structure composition was
assessed using SELCON3 via Dichroweb.
AnalyticalUltracentrifugation—Sedimentation velocity experi-
ments were performed in a Beckman Optima XL-I analytical
ultracentrifuge equilibrated at 20 °C with 400 l of 2 mg/ml
protein in 25 mM sodium phosphate, 100 mM NaCl at pH 7 in
the presence and absence of 1 mMTCEP. Proteins were spun at
50,000 rpm (201,500  g), and 200 scans were collected using
interference optics. Scans were analyzed and refined using
SEDFIT (23), and data are presented with GraphPad Prism 4.
Dynamic Light Scattering—Toanalyze the size distribution of
particles within purified protein solutions, dynamic light scat-
tering was performed using a Malvern Zetasizer Nano S DLS
machine. Protein samples were buffer-exchanged into 25 mM
sodium phosphate, pH 7, 100 mM NaCl, 5 mM -mercaptoeth-
anol, and contaminants were removed by centrifugation
(16,000  g, 10 min, 4 °C). The experiment was performed at
21 °C, and three sets of scans were performed per sample.
Experimental data were analyzed using the Dispersion Tech-
nology Software 5.02 (Malvern Instruments).
Homology Modeling and Bioinformatics—Amino acids cor-
responding to the RIP2 CARD (amino acids 435–528) were
submitted to the homology search server pGENThreader (24).
The top hit was the NOD1 CARD (Protein Data Bank code
2DBD; score, 44.083; p value, 0.002), which was used as a tem-
plate for model building with Modeler version 9.8 (25). Side-
chain conformations were optimized using SCWRL4 (26)
before refinement using Modeler. Stereochemistry was ana-
lyzed using MolProbity (27), which indicated excellent stereo-
chemistry for the RIP2 CARD model. 97.6% of residues were
found in the favored regions of the Ramachandran plot; there
were no outliers, and no residues possessed poor rotamers.
Full-length human NOD1 (GenBank accession number
NP_006083.1) was used to perform aBLASTp (28) search of the
non-redundant proteindatabase, and31 full-lengthNOD1ortho-
logueswere collated andalignedusingClustalW2 (29).Thepoten-
tial impact of NOD1 CARD mutants was predicted using Poly-
Phen-2 (30) using the classifier model HumDiv and genome
assembly GRCh37/hg19. The interface between subunits in the
NOD1crystal dimer structurewas analyzedusingPDBePISA (31).
SNP frequencies were retrieved from the Exome Variant Server.
RESULTS
Revisiting the Nature of the Interface between NOD1 and
RIP2—Protein/protein interactions and the assembly ofmacro-
molecular signaling platforms are essential for innate immune
signal transduction. For NOD1, a key interaction is between its
CARD and the CARD of the adaptor protein RIP2. Previously,
three acidic residues (Glu-53, Asp-54, and Glu-56) in helix 3 of
the NOD1 CARD and three basic residues (Arg-444, Arg-483,
and Arg-488) in the RIP2 CARD were identified as key media-
tors of the NOD1-RIP2 interaction (Fig. 1A-C) (18). This study
also showed that double and triple mutants in helix 2 of the
NOD1CARDabrogated signaling and seriously impaired inter-
action with RIP2. Recently, we have demonstrated that NOD1
Glu-56 may in fact not be critical for this interaction (32).
Meanwhile, Fridh and Rittinger (33) have shown that the
NOD2-RIP2 interfacemay differ from that betweenNOD1 and
RIP2 and could involve basic residues on NOD2 and acidic res-
idues on RIP2; mutation of a number of these acidic RIP2 resi-
dues also stopped interaction with NOD1. Other recent stud-
ies indicate that CARD-CARD interactions involve multiple
interfaces and may have a complexity comparable with that
of death domains (34–36). In light of this, we decided to take
a closer look at the nature of the interaction between NOD1
and RIP2.
We began by analyzing the distribution of residues impli-
cated in NOD1 and RIP2 CARD-CARD interaction in the con-
text of the three types of interface (Table 1) defined for mem-
bers of the death domain superfamily in the structure of the
PIDDosome (p53-induced death domain protein) (37). Except
forArg-69, which is found in helix 4,NOD1 residues implicated
as important for RIP2 interaction mapped to helices 2 and 3
(Table 2 and Fig. 1,A andB). As the structure of the RIP2CARD
FIGURE 1.Key functional residues in the CARDof NOD1 and RIP2. Previously identified functionally important amino acids weremapped in stick represen-
tation onto themonomeric (A) and dimeric (B) forms of the NOD1CARD (Protein Data Bank codes 2DBD and 2NZ7, respectively) and amodel of the RIP2 CARD
(C). For the NOD1 CARDs, mutation of residues colored blue (Val-41, Asp-42, Glu-53, Asp-54, Glu-56, and Arg-69) has been shown to inhibit both receptor
signaling and RIP2 binding; for residues colored gray (Leu-44) signaling was impaired, but RIP2 binding was unaffected; and residues colored orange (Glu-84
andTyr-88) havebeen implicated inubiquitinbinding, and theirmutationenhances signaling.Helices 2 and3 inNOD1are labeled. InRIP2, the residues are split
into two potential interfaces containing Arg-444, Arg-483, Arg-488, and Asp-492 (yellow) and Asp-461, Glu-472, and Glu-475 (orange).
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has not yet been determined, we generated a homology model
to approximate the position of the helices. Residues in RIP2
identified by Manon et al. (18) and Fridh and Rittinger (33) as
important for NOD1 interaction are dispersed across helices 1,
2, 3, and 4 but cluster into two distinct surfaces (Fig. 1C).
In its crystalline form, theNOD1CARD forms a dimer due to
helix swapping between helices 1 and 6 (Fig. 1B) (38, 39). Fur-
ther stabilization is provided by an interprotomer disulfide
bond mediated by Cys-39. This residue is conserved across
NOD1 species (Fig. 2). We used PDBePISA to determine the
contribution of residues in NOD1 to the dimer interface (Table
2 and Fig. 1B). Residues across helices 1, 2, 5, and 6 and the
connecting loops contributed to the dimer interface. Only helix
2 is currently implicated in bothNOD1 dimerization and signal
transduction (Table 2).
Mutation of NOD1 Helix 2 Results in Impaired Activation of
NFB by NOD1—HEK293 cell-based NFB reporter assays
were used to assess the signaling capabilities of wild-type
TABLE 1
Regions contributing to death domain family member interaction interfaces
TABLE 2
NOD1 residues involved in dimerization and signal transduction
ND, not determined. Dimer interface data were obtained from PDBePISA analysis. Functional data were obtained from the sources indicated.
NOD1 residue Structural location
Contribution to dimer
interface
Impact on NOD1 functionChain A Chain B
Å2
Leu-22 Helix 1 15.37 15.18 ND
Leu-23 Helix 1 0.50 0.00 ND
Asn-26 Helix 1 21.80 19.03 ND
Leu-29 Helix 1 37.82 37.12 ND
Leu-30 Helix 1 19.47 22.25 ND
His-33 Helix 1 57.02 66.53 ND
Ile-34 Helix 1 20.71 15.90 ND
Arg-35 Helix 1-helix 2 loop 86.68 99.79 ND
Asn-36 Helix 1-helix 2 loop 60.34 48.55 ND
Gln-38 Helix 2 50.24 55.41 ND
Cys-39 Helix 2 61.48 53.99 ND
Leu-40a Helix 2 3.79 1.17 None
Val-41a Helix 2 0.00 0.00 V41A and V41Q both slightly reduce signaling, and V41A has
reduced RIP2 binding
Asp-42a Helix 2 35.51 36.16 Inhibits signaling as double/triple mutant
Asn-43 Helix 2 20.64 17.32 ND
Leu-44a Helix 2 0.00 0.00 Extensive inhibition of signaling; normal RIP2 binding
Lys-46 Helix 2 32.72 30.73 ND
Asp-48a Helix 2-helix 3 loop 0.00 0.00 None
Ala-52a Helix 3 0.00 0.00 None
Glu-53a,b Helix 3 0.00 0.00 Abrogates signaling and RIP2 interaction
Asp-54a,b Helix 3 0.00 0.00 Abrogates signaling and RIP2 interaction
Glu-56a,b Helix 3 0.00 0.00 E56K abrogates signaling and RIP2 interaction; E56A does not
Ile-57a Helix 3 0.00 0.00 None
Lys-67a Helix 4 0.00 0.00 None
Arg-69a,c Helix 4 0.00 0.00 Abrogates signaling; significant reduction in RIP2 binding
Glu-84c Helix 5 0.00 0.00 Implicated in ubiquitin binding; enhanced signaling on mutation
Leu-87 Helix 5 24.03 22.95 ND
Tyr-88c Helix 5 0.00 0.00 Implicated in ubiquitin binding; enhanced signaling on mutation
Leu-90 Helix 5 37.02 34.63 ND
Gln-91 Helix 5 34.71 37.96 ND
Gln-92 Helix 5 0.17 7.20 ND
Leu-93 Helix 5 48.62 55.02 ND
Ala-94 Helix 5 64.12 66.23 ND
Asp-95 Helix 5 48.40 51.00 ND
Ala-96 Helix 5 54.95 55.68 ND
Tyr-97 Helix 5 141.34 141.41 ND
Val-98 Helix 5-helix 6 loop 38.07 35.90 ND
Asp-99 Helix 5-helix 6 loop 59.20 69.47 ND
Leu-100 Helix 6 79.12 87.33 ND
Arg-101 Helix 6 82.71 71.36 ND
Trp-103 Helix 6 102.87 103.49 ND
Leu-104 Helix 6 82.34 85.83 ND
Leu-105 Helix 6 0.68 0.00 ND
a Manon et al. (18).
b Boyle et al. (32).
c Ver Heul et al. (19).
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NOD1 and various CARD mutants across helices 2 and 3.
Mutants were generated by site-directed mutagenesis in
pUNO-hNOD1, transiently transfected into HEK293 cells, and
stimulated with increasing doses of the NOD1 agonist iE-DAP
or a constant dose of an inactive control compound, iE-Lys.
Consistent with previous work (18), the helix 3 mutants E53K,
D54K, and E56K all abrogated NOD1 signaling (Fig. 3A). The
other helix 3 mutant tested, A55V (which exists as a polymor-
phism in 1 in 2,000 African-Americans), activated NFB at a
level at least comparable with the wild-type protein.
Double and triple mutants in helix 2 of the NOD1 CARD
have been shown to disrupt signaling and interaction with RIP2
possibly due to structural perturbation (18). However, with the
exception of L44A, single mutants have not been shown to dis-
rupt NOD1-mediated NFB signaling. We confirmed the
impact of L44AonNOD1 signaling (Fig. 3B).We also tested the
impact of mutating the surface-exposed residue Asn-43. This
residue was mutated to an alanine, a serine (a reported poly-
morphism in theNCBI database), and an aspartic acid (tomain-
tain size but change residue properties from polar to acidic).
We found that N43D failed to respond to any ligand stimula-
tion, and both N43A and N43S were significantly impaired in
their response at ligand concentrations of 100 and 1000 ng/ml
(Fig. 3B). Interestingly, N43A, N43D, and L44A showed a sig-
nificant reduction in basal signaling (Fig. 3B). When compared
with these basal levels, the fold activation following ligand stim-
ulation of N43A and L44A, but not N43D, was similar to the
change in wild-type NOD1 albeit with a somewhat lower level
of signaling response. This was not the result of dramatic
changes in receptor expression level (Fig. 3C). Together the
various changes in basal and ligand-induced signaling suggest
an important role for helix 2 in NOD1 signaling. None of the
FIGURE2.ClustalW2multiple sequencealignmentof theNOD1CARDfrom31different species.For clarity, humanNOD1hasbeenplacedat the topof the
alignment. The conserved Cys-39 residue and the core RIP2 bindingmotif are highlighted in yellow and cyan, respectively, across all species, whereas residues
involved in the dimer interface of the NOD1 CARD crystal structure are underlined in the human sequence. In the consensus sequence, complete conservation
is denoted by an asterisk (*), strongly conservative substitutions are denoted by a colon (:), and partially conservative substitutions are denoted by a dot (.).
GenBank accession numbers for the sequences are as follows: Gallus gallus, XP_418777.2; Meleagris gallopavo, XP_003207269.1; Taeniopygia guttata,
XP_002196320.1; Anolis carolinensis, XP_003222248.1; Rattus norvegicus, NP_001102706.1; Mus musculus, NP_766317.1; Cricetulus griseus, XP_003507840.1;
Heterocephalus glaber, EHB11938.1; Oryctolagus cuniculus, XP_002713781.1; Homo sapiens, NP_006083.1; Pan troglodytes, XP_001165528.1; Pongo abeli,
XP_002818130.1; Nomascus leucogenys, XP_003270528.1;Macaca mulatta, EHH17407.1;Macaca fascicularis, EHH52238.1; Callithrix jacchus, XP_002751479.1;
Sus scrofa, NP_001107749.1; Bos taurus, XP_598513.3; Canis lupus familiaris, XP_539499.2; Ailuropoda melanoleuca, XP_002919315.1; Equus caballus,
XP_001499616.1; Loxodonta africana, XP_003407068.1; Ornithorhynchus anatinus, XP_001512159.1; Monodelphis domestica, XP_001381520.2; Xenopus (Silu-
rana) tropicalis, XP_002937900.1; Oreochromis niloticus, XP_003446247.1; Paralichthys olivaceus, AFD29894.1; Ctenopharyngodon idella, ACX71752.1; Labeo
rohita, AFE61355.1; Danio rerio, XP_002665106.2; and Ictalurus punctatus, NP_001186996.1. H1–H6, helices 1–6.
FIGURE3.MutationofAsn-43 results inNOD1dysfunction in response to ligandstimulation.NFB luciferase reporter assayswere performed inHEK293
cells using wild-type NOD1 (WT) and receptors mutated in helix 3 (A) or helix 2 (B). DNA (0.1 ng/well) and the indicated concentration of stimulatory
(iE-DAP) or 100 ng/ml of the control ligand ie-Lys (C100) were transfected into 96-well plates. After 24 h, cells were lysed, and NFB activity was
determined. Results show the average of four independent experiments, and * represents p 0.0005 compared with wild type. Error bars indicate S.E.
C, immunoblots of expression levels of NOD1WT andmutant constructs. Immunoblot samples (3 g of DNA/well in a 6-well plate) were lysed after 24 h
and probed with the indicated antibodies. Immunoblots are representative of at least three separate experiments. D, WebLogo representation of NOD1
CARD helices 2 and 3, the core region of NOD1 implicated in signaling and RIP2 interaction. Residue numbering matches the human sequence. Residue
height represents the degree of conservation across 31 full-length NOD1 sequences from different mammalian species. Absolutely conserved residues
are indicated with an arrowhead. E, Leu-44 (blue) is an internal hydrophobic residue, and Asp-54 forms an internal salt bridge with Lys-78. The salt bridge
is denoted by a dashed black line and has a distance of 3.8 Å.
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mutant constructs behaved as dominant negatives when tested
(data not shown).
The functional importance of the residues identified in heli-
ces 2 and 3 forNOD1 function is highlighted by their evolution-
ary conservation (Figs. 2 and 3D) (32). Interestingly, Cys-39,
Asn-43, Leu-44, Glu-53, Asp-54, and Glu-56 were the only res-
idues in this region showing absolute conservation. Of these,
Cys-39 has already been shown to be important in NOD1
CARD dimerization, whereas Glu-53, Asp-54, and Glu-56 are
all crucial for RIP2 interaction and signal transduction. On
evaluation of the tertiary structure of NOD1, it is clear that
Leu-44 forms part of the hydrophobic core (Figs. 1A and 3E)
and that Asp-54 is actually involved in an internal salt bridge
with Lys-78 (Fig. 3E), hence explaining why mutation of these
residues impairs NOD1 function. Consequently, the complete
cross-species conservation of Asn-43 is strong support for a
crucial role of this residue in NOD1 function.
Mutation of Residues in NOD1 Helices 2 and 3 Does Not
Affect Membrane Recruitment—Upon activation, NOD1 and
NOD2 undergo partial relocalization to the plasma membrane
to interact with RIP2 and mediate signaling (5–8). We there-
fore checked the cellular distribution of a representative selec-
tion of our constructs. Indirect immunofluorescence studies
showed the cellular localization of N43S, D48K, A55V, and
E56K to be broadly comparable with that of wild-type NOD1.
Each protein showed localized patches of membrane-associ-
ated protein in addition to a dispersed cytoplasmic staining
(Fig. 4A). Consistent with previous reports, a Walker A muta-
tion, K208R, caused loss ofmembrane localization and a strong,
diffuse cytoplasmic signal (6, 40) (Fig. 4A). Subcellular fraction-
ation comparing the proportion of NOD1 proteins in the cyto-
plasm and the membrane confirmed this pattern of distribution.
As expected, Flotillin-2 and GAPDH were almost exclusively
membrane-associated and cytoplasmic, respectively, showing the
purity of the subcellular fractions (Fig. 4B). Consequently, the
impaired NFB signaling observed with the mutants N43S and
E56K in the NOD1 CARD does not result from either a loss of
protein expression or protein mislocalization.
Mutation of Surface-exposed Residues Does Not Perturb the
Secondary Structure of the NOD1 CARD—The lack of signifi-
cant changes in the subcellular localization of the NOD1
mutants described above suggests that these constructs are
folding properly. However, it does not provide conclusive proof
of correct folding and does not inform on any of the other
mutants. To confirm the impact of the point mutants on pro-
tein folding, we expressed wild-type and mutant recombinant
NOD1 CARD domains (amino acids 15–110) in Escherichia
coli. Neither the L44A nor D54K construct showed any protein
expression, consistent with a critical structural role in the
hydrophobic core and in forming internal salt bridges, respec-
tively. All other constructs were expressed and purified in a
manner comparable with the wild-type CARD and produced
circular dichroism spectra consistent with an -helical protein
(Fig. 5). SELCON3 analysis indicated that all NOD1CARDpro-
teins were 80% helical, 5% turn, and 15% unordered. Hence,
although the defect in signaling when mutating Leu-44 or
Asp-54 may result from protein misfolding, this is highly
unlikely when mutating Asn-43, Glu-53, or Glu-56.
Signaling-defective Mutants Can Still Interact with the RIP2
CARD—Experiments with double and triple mutants in helix 2
have led to the suggestion that helix 2 helps stabilize interaction
with RIP2 (18). We hypothesized that the impaired signaling
upon mutation of Asn-43 could result from disruption of the
interaction with RIP2. To test this, we performed co-immuno-
precipitations in HEK293 cells transfected with pCI-RIP2-
Myc-His and both wild-type and mutant pCMV-FLAG-NOD1
constructs. As expected given their normal signaling profile,
wild-type NOD1, D48K, and the helix 3 polymorphism A55V
all immunoprecipitated RIP2. The inactive mutant E56K did
not (Fig. 6A) (18). However, RIP2 was successfully immunopre-
cipitated by the signaling-impairedmutant N43S (Fig. 6A). The
same pattern of immunoprecipitation was seen with (A) and
without (B) stimulation by iE-DAP (Fig. 6). Therefore, the
impaired NFB-mediated signaling of N43S is not the result of
a failure to recruit RIP2 to the signaling complex. Togetherwith
the results of others (18) this suggests that singularmutations of
helix 2 do not disrupt interaction between NOD1 and RIP2 but
can, however, interfere with signaling.
Immunoprecipitation studies do not rule out the possible
involvement of other bridging proteins in the interaction
between NOD1 and RIP2. We returned to recombinant pro-
teins to address this possibility. Although recombinant NOD1
CARD constructs could be readily expressed and purified to
homogeneity, we were unable to produce sufficiently stable
recombinant RIP2 CARD to facilitate biophysical or structural
study of the NOD1-RIP2 interaction. To overcome this prob-
lem, we modified the recently reported co-expression system
used to study interaction between NOD2 and RIP2 (33). We
expressed either GST-NOD1 or His-MBP-NOD1 fusions and
GB1-RIP2 fusion CARDs in separate cultures, resuspended the
cells in lysis buffer, and pooled the samples prior to sonication.
Lysed cells were clarified, and the soluble fraction was mixed
with affinity resin to purify the NOD1 CARD. Co-purification
of GB1-RIP2 was determined by PAGE. Using this novel co-
sonication techniquewewere able to show that, consistentwith
the co-immunoprecipitation study, recombinant RIP2 protein
was pulled down using wild-type NOD1 CARD and the
mutants D48K, N43S, N43A, N43D, and A55V (Fig. 6C). As
expected, E53K failed to interact with RIP2 as did the negative
controls of GST alone and resin alone. Interestingly, E56K,
which did not immunoprecipitate RIP2 in HEK293 cells, was
able to pull downRIP2 in this recombinant system. Thismay be
due to the higher protein concentrations in the pulldown sys-
tem or, consistent with our own published data (32), reflect a
less critical role for Glu-56 in maintaining interaction with
RIP2. Due to the inability of either D54K or L44A to be
expressed as recombinant proteins in E. coli, we were unable to
assess their interaction with RIP2 by this method.
We also used our co-sonication assay to gain further insight
into the role of residues on the surface of RIP2 that are impor-
tant for interaction with NOD1. We prepared a series of
mutants in the RIP2CARDbased on their proximity to the core
basic residues (Arg-444, Arg-483, and Arg-488) previously
identified to be involved inNOD1 interaction (18).Mutation of
Val-448, Thr-484, Ser-485, Lys-486, Gln-497, Asp-446, and
Glu-522 had no impact on the interactionwithNOD1 (Fig. 6D).
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In contrast, in addition to Arg-444, Arg-483, and Arg-488,
mutating Lys-443 and Tyr-474 stopped interaction between
NOD1 and RIP2 CARDs (Fig. 6D).
Mutating Asn-43 inHelix 2 Alters the Propensity of theNOD1
CARD to Form Dimers—Residues in helix 2 contribute to the
dimer interface in the NOD1 crystal structures (Table 2). This
led us to ask whether alterations in dimer formation could con-
tribute to the functional changeswe had observed.Weused size
exclusion chromatography of recombinant NOD1 CARD con-
structs to determine the oligomeric status of NOD1 helix 2 and
helix 3 mutants (Fig. 7, A and B). In the absence of reducing
agent, wild-type NOD1 CARD showed similar proportions of
both monomer and dimer (Fig. 7A). As expected, replacement
of Cys-39 with serine resulted in a loss of the dimeric form. The
helix 2 mutants N43S and D48K were both predominantly
dimeric, whereas N43D eluted in the void volume due to the
formation of large aggregates. Aggregate formation in the
absence of reducing agent by N43D was confirmed using
dynamic light scattering (Fig. 7C). Helix 3 mutants showed evi-
dence of bothmonomeric and dimeric NOD1 in the absence of
reducing agent (Fig. 7A, bottom panel). In the case of E53K and
E56K, the dimeric peak was broad, suggesting a potentially het-
erogenous population. In the presence of reducing agent, wild-
type NOD1 CARD and all of the helix 2 and helix 3 mutants
tested with the exception of N43S were almost entirely mono-
meric (Fig. 7B). N43S in contrast maintained the same elution
profile as seen under non-reducing conditions, indicating that
the protein was almost entirely dimeric.
To further study these observations, we analyzedN43S, wild-
type NOD1, and the helix 3 mutant A55V by analytical ultra-
centrifugation in both the absence and presence of reducing
agent. In the presence of reducing agent, wild-type NOD1
CARD, N43S, and A55V were predominantly monomeric (Fig.
7D). The reduction in the proportion of dimer for N43S under
these conditions compared with size exclusion chromatogra-
phy likely results from the use of TCEP, a stronger permanent
reducing agent, in the analytical ultracentrifugation. Without
reducing agent, a considerable proportion of each protein and
almost all of N43S existed as a dimer (Fig. 7D). Hence,mutation
of Asn-43 in helix 2 alters the likelihood of higher order struc-
ture formation between NOD1 CARD protomers that in turn
could inhibit signaling.
The NOD1-RIP2 Interactions Are Consistent with Involve-
ment of Both a Type I and Type III Interface—Death domains
interact using specific interfaces (Table 1). Until recently, the
only structure of a CARD complex involved a type III interface
between theCARDs ofApaf-1 and procaspase-9 (41). However,
recent structures have demonstrated that purified CARDs can
use all three interaction types to form oligomeric (36) and poly-
meric (42, 43) complexes.
Helices 1 and 4 of the RIP2 CARD and helices 2 and 3 of the
NOD1 CARD are implicated in RIP2-NOD1 interaction, sug-
gesting involvement of a type I interface (18) (Table 1). In light
of our observations that mutation of the surface-exposed
Asn-43 in helix 2 of the NOD1 CARD still permits interaction
with RIP2, we investigated the potential interfaces involved in
the NOD1-RIP2 interaction via comparison with solved
CARDCARD structures.
The type I CARD interaction between Apaf-1 and pro-
caspase-9 uses a type Ia patch centered on two basic residues
and a type Ib patch centered on two acidic residues (41).
Sequence alignments of the CARDs of Apaf-1, procaspase-9,
NOD1, RIP2 and NOD2 CARDa (Fig. 8A) indicated that both
the NOD1 CARD and NOD2 CARDa contain the same type Ia
basic patch as procaspase-9.Mutation of these basic residues by
Manon et al. (18) (NOD1 Arg-69) and Fridh and Rittinger (33)
(NOD2 Arg-38 and Arg-86) abrogated interaction with RIP2.
The opposing type Ib patch on RIP2 involves Asp-461 and Tyr-
474 (Fig. 8A). Mutation of Asp-461 disrupts the interaction of
RIP2withNOD1orNOD2 (33), althoughwehave shown in this
work that Tyr-474 is also necessary for NOD1 interaction. The
position of these residues maps well to those in the Apaf-1pro-
caspase-9 structure (Fig. 8B). We can therefore conclude that
theNOD1RIP2 complex involves a type I interaction utilizing a
type Ia basic patch in the NOD1 CARD and a type Ib acidic
patch on RIP2.
RIP2 also contains a basic type Ia patch consisting of Arg-444
andArg-488 (Fig. 8A) that is essential for theNOD1-RIP2 inter-
action (18). However, mutation of the NOD1 type Ib surface
(Asp-42 (18) and Ala-55 (this work)) (Fig. 8a) does not signifi-
cantly affect signaling (18). As such, theNOD1RIP2 complex is
not likely to include a RIP2 type Ia-NOD1 type Ib interaction.
However, the importance of the RIP2 1a interface suggests that
the overall complex is likely to involve a RIP2-RIP2 type I
interaction.
Glu-53 andGlu-56 from theNOD1CARDandArg-483 from
the RIP2 CARD are also important for maintaining the interac-
FIGURE 4. The cellular localization of NOD1 SNPs is comparable with that of wild-type NOD1. A, immunofluorescence studies of FLAG-tagged NOD1
constructs transiently transfected into HeLa cells using FuGENE 6. NOD1 proteins (white in top panels and red in bottom panels) were detected with mouse
anti-FLAG M2 and goat anti-mouse Alexa Fluor 546 antibodies. DNA (blue) was stained with DAPI, and actin (green) was stained with phalloidin-FITC. B,
subcellular fractionation of FLAG-NOD1 constructswas performedusing a Subcellular Fractionation kit. Sampleswere probedwith antibodies against FLAG to
detect NOD1, Flotillin-2 to detect themembrane fraction, and GAPDH to detect the cytoplasmic fraction. T, total lysate; C, cytoplasmic fraction;M, membrane
fraction. Images are representative of at least two (A) or three (B) independent experiments. Scale bar, 10 m.
FIGURE 5. The secondary structure of NOD1 SNPs is unaltered. Recombi-
nant NOD1 CARDs at a concentration of 0.4 mg/ml in 25 mM sodium phos-
phate, pH 7.0, 100 mM sodium fluoride, 1 mM TCEP were analyzed by circular
dichroism. The far-UV (190–260 nm) spectra indicate a strong -helical trace
for the wild-type andmutant CARD constructs as labeled with amaximum at
193nmandminimaat 208and222nm. [] is themean residueellipticity. Plots
are representative of at least three independent experiments.
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FIGURE 6. Asn-43 mutants still interact with RIP2. Co-immunoprecipitation experiments were performed in HEK293 cells transfected with the constructs
detailed in either the presence (A) or absence (B) of stimulation with 100 ng/ml iE-DAP. Complexes were immunoprecipitated using anti-FLAG antibody
immobilized on Protein G-coated Dynabeads and analyzed with the antibodies detailed. Blots are representative of at least three separate experiments.
co-purification of E. coli-expressedGST-NOD1CARDandGB1-RIP2-CARD (C) or His-MBP-NOD1-CARDandGB1-RIP2-CARD (D). Expressedproteinswere pooled
during lysis, co-purified with glutathione-Sepharose or amylose resin as appropriate, and detected by Instant Blue (Expedeon) staining. In both C and D, T
represents total lysate, and E represents eluted fraction. The position of recombinant proteins is marked. Images are representative of at least three indepen-
dent experiments.
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tion between NOD1 and RIP2. We compared the locations of
these residues with the interfaces reported in the recent oligo-
meric RIG-I CARD complex (36) and found that they corre-
sponded to the type III interface (Fig. 8C). Specifically, NOD1
residues form part of a type IIIa interface, and the RIP2 residue
is part of a type IIIb interface. Together these observations sug-
gest that NOD1 and RIP2 CARDs mediate formation of an
oligomeric structure involving both type I and type III
interfaces.
Given the increased propensity for N43S to form dimers, we
also investigated the availability of the NOD1 type I and type III
interfaces in the dimeric formof theNOD1CARD. Importantly
and consistent with the ability of N43S to still bind RIP2, both
the type I and type III interface reside on the external surface of
FIGURE 7.MutationofAsn-43 inhelix 2 alters themultimerizationproperties of theNOD1CARD.A and B, size exclusion chromatography of recombinant
NOD1 CARD constructs from helix 2 (top) and helix 3 (bottom) in the absence (A) or presence (B) of the reducing agent DTT. Constructs are colored as follows:
wild-type NOD1, black; C39S, red; D48K, brown; N43D, gray; N43S, blue; E53K, orange; A55V, yellow; and E56K, green. C, dynamic light scattering confirms the
aggregation of N43D in the absence of reducing agent. Red line, no reducing agent; black line, reducing agent (DTT) present. D, sedimentation velocity
analytical ultracentrifugation ofwild-type, N43S, andA55V recombinantNOD1CARDs in the absence (left-hand panels) andpresence (right-hand panels) of the
reducing agent TCEP.Molecularmasses as determined by the use of standards are denoted by arrowheads inA and B. Calculatedmolecularmasses are labeled
above the individual peaks in D. Data are representative of at least three independent experiments.mAU, milliabsorbance units; d.nm, diameter in nm.
FIGURE 8. Involvement of type I and type III interfaces in the interaction between NOD1 CARD and RIP2 CARD. A, structure-based alignment of the
regions involved in a type I interface. Type Ia basic residues (blue) and type Ib acidic residues (red) were identified from the crystal structure of Apaf-
1procaspase-9 CARD complex (Protein Data Bank code 3YGS (41)). Internal hydrophobic residues are highlighted yellow. B, the type I interface between
procaspase-9 (top left) and Apaf-1 (top right) was used to align the position of the NOD1 (bottom left) and RIP2 (bottom right) CARDs, consistent with a type I
interaction (bottom). The type Ia patch on procaspase-9 andNOD1 and the type Ib patch on Apaf-1 and RIP2 are colored blue and red, respectively. Side chains
of residues reported to be critical for the interaction are shown as stick representations. C, the type III interface between RIG-I CARDs (Protein Data Bank code
4NQK (36)) (top)wasused to identify thepotential type III interfaces inNOD1 (bottom left) andRIP2 (bottom right). The acidic type IIIa surfaceonNOD1 is colored
red, and the basic type IIIb surface on RIP2 is colored blue. Side chains of residues reported to be critical for the interaction are shown as stick representations.
D, the type I (blue) and type III (red) interfaces of NOD1 remain available for interaction with RIP2 in the helix-swapped NOD1 CARD dimer (Protein Data Bank
code 2NSN (39)). TheNOD1protomers are shown in yellow and gray, and theCys-39-mediateddisulfide bond is shown in orange. For clarity, the type I and type
III interfaces are only included on one protomer. Structural figures were generated using PyMOL. Key helices on NOD1 and RIP2 are labeled (H1–H4).
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the dimer (Fig. 8D). Consequently, RIP2 should still be able to
bind dimeric NOD1 butmay not be capable of forming a higher
order oligomeric structure necessary for successful signaling.
DISCUSSION
Immune signaling pathways require tight regulation and
control to ensure an appropriate cellular response to pathogens
and cellular danger signals. The NLR proteins NOD1 and
NOD2 propagate signaling through engagement of the adaptor
protein RIP2. In the work presented here, we focused on the
nature of the interaction between the CARDs of NOD1 and
RIP2. Using cell-based techniques and recombinant protein
analysis we showed that helix 2 of the NOD1 CARD is not part
of the interface involved in RIP2 binding. However,mutation of
the residue Asn-43 in helix 2 impaired receptor signaling most
likely as a result of alterations in the propensity of the NOD1
CARD to self-associate. In addition, we identified two addi-
tional residues in RIP2, Lys-443 and Tyr-474, mutation of
which abrogated interaction with NOD1.
Disruption of helix 2 in NOD1 affects receptor function but
not as a result of inhibiting the interaction with RIP2 (Figs. 3
and 6 and Ref. 18). Helix 2 is also the only region of the NOD1
CARD implicated in both CARDCARD dimerization and sig-
naling function (Table 2). Although the NOD1 CARD forms a
dimer in the crystal structure (38, 39), clear cut evidence for
physiological formation of the dimer or a potential role in the
activation of signaling through reduction of the Cys-39-medi-
ated disulfide has yet to be demonstrated. However, our obser-
vations that N43S had an increased propensity to form dimers
and that N43D formed larger aggregates suggest that these pro-
cesses may be intrinsically linked and could provide a potential
mechanism for receptor dysfunction.
More specifically, residues in NOD1 that are important for
RIP2 binding remain accessible in the dimeric form of the
NOD1 CARD (Figs. 1B and 8D). These include Arg-69 (type Ia
basic interface) and Glu-53 and Glu-56 (type IIIa acidic inter-
face). Residues in NOD1 recently reported to bind ubiquitin
(Glu-84 and Tyr-88 (19)) are also accessible in the dimeric
form. Consequently, the ability of RIP2 to be recruited to and
bind the NOD1 CARD in the monomeric and dimeric forms is
to be expected. However, the relative orientation of the RIP2
molecules recruited may differ for the monomeric and the
dimeric forms of the NOD1 CARD. Post-translational modifi-
cation of RIP2 via ubiquitination and/or phosphorylation has
been reported to play a crucial role in signal transduction (9,
10). Indeed, autophosphorylation of Tyr-474 in the RIP2CARD
is crucial for the full engagement of signaling following activa-
tion of NOD2. It is tempting to speculate that alterations in
post-translational modifications of RIP2 resulting from altered
protein accessibility could explain the impact of Asn-43 muta-
tion on receptor signaling. This argument is strengthened by
the direct involvement of RIP2 Tyr-474 in the interaction with
NOD1 (Fig. 6D). To fully understand themechanistic impact of
these mutations, a more detailed study investigating post-
translational modifications of RIP2 and NOD1 is required.
The alteration in the propensity of the NOD1 CARD to
dimerize and/or multimerize following mutation of Asn-43
draws parallels with other recently described immune signaling
networks. For instance, studies on the CARMA1/Bcl10/
MALT1 signalosome (42) and of RIG-I (36) and MDA-5 (44–
46) signaling serve as a reminder of the potential importance of
CARD oligomerization in innate immune signaling. These
studies coupledwith recent work looking at aggregation of apo-
ptosis-related speck-like protein containing a CARD (ASC)
raise the possibility that the NOD1 CARD may be functioning
as a nucleation point for subsequent assembly of a RIP2 oli-
gomer (47, 48). It should be noted that for an NLR-related fam-
ily of proteins in plants dimerization of their coiled coil and
Toll-interleukin 1 receptor effector domains plays a pivotal role
in activation and signaling (49, 50), making it tempting to spec-
ulate that regulation of the oligomerization status of NLR effec-
tor domains is a conserved feature of NLR signaling.
Currently, we lack high resolution structural information for
a complex between an NLR effector domain and its adaptor
protein. However, the structures of other death domain fold
proteins, such as the PIDDosome (37), show that death domain
family members can form multiprotein complexes with each
subunit utilizing at least three independent types of interaction
(types I, II, and III) (37). A type I interaction, exemplified by the
CARDs of Apaf-1 and procaspase-9, contains residues from
helices 2 and 3 of one protein (a Ib interface) interacting with
residues from helices 1 and 4 from a second protein (a Ia inter-
face). It has been assumed previously that all CARDCARD
complexes would adopt a conformation very similar to that of
Apaf-1procaspase-9. The recent crystal structure of the RIG-I
CARD complex makes it clear that this is not the case and that
CARD-CARD interactions include multiple interface types
(36). Our analysis and that of others (18) highlight the impor-
tance of helix 3 in the NOD1 CARD for interaction with RIP2
but also reveal that helix 2 is not directly involved in the inter-
face. By comparing the locations of residues crucial for the
NOD1-RIP2 CARD interaction with those involved in the
Apaf-1procaspase-9 and RIG-I structures, we have shown that
both type I and III interfaces are likely to be involved in NOD1-
RIP2 interface. Coupled with the potential involvement of a
type I RIP2-RIP2 interface, this would be consistent with pro-
duction of a larger oligomeric structure following signal activa-
tion. However, confirmation of this will have to wait until we
have a molecular structure of the RIP2NOD1 CARD complex.
The complexity of CARD-mediated signaling has been high-
lighted by a number of recent studies. Kersse et al. (34) have
identified multiple interfaces in interactions involving the
CARDof procaspase-1. For example,Asp-27 is crucial for inter-
action with ASC via a type I interface, and Arg-45 is part of a
proposed type III interfacemediating auto-oligomerization and
facilitating interaction with RIP2. Meanwhile, Proell et al. (35)
have shown that multiple interaction surfaces on the CARD of
ASC are crucial for inflammasome formation and interaction
with caspase-1. Mutation of two patches, one composed of res-
idues in helices 1, 3, and 4 and the other from residues in helices
2 and 3, resulted in a loss of ASC focus assembly (35). Further-
more, Fridh and Rittinger (33) identified clear differences in the
binding surfaces involved in NOD1-RIP2 and NOD2-RIP2
interactions. NOD1 and RIP2 interact via acidic and basic
patches on the respective proteins, whereas basic residues on
the first CARD of NOD2 interact with acidic residues on RIP2.
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They also identified acidic residues in RIP2 (Asp-461, Glu-472,
Glu-475, and Asp-492) that contribute to the interaction with
NOD1, suggesting either a larger interaction surface composed
of acidic and basic patches or an alternative interface confor-
mation. We identified two further RIP2 residues involved in
NOD1 binding. The first of these, Lys-443, fits firmly with the
regions proposed by Manon et al. (18). The second, Tyr-474, is
located in the group of residues identified by Fridh and Rit-
tinger (33) and is autophosphorylated followingRIP2 activation
by NOD2 (9). Mutation of Tyr-474 to Phe reduced but did not
stop the interaction between NOD2 and RIP2 (9). Together
these observations suggest that Tyr-474 and surrounding resi-
dues may serve important functional roles in signal transduc-
tion for both NOD1 and NOD2 pathways. Our observations
help to confirm the widening view that CARD-CARD interac-
tions are indeed complex and highlight the need for further
studies to address not just the structural basis of complexes,
such as that formed by NOD1 and RIP2, but also the precise
nature and regulation of the post-translational modifications
involved in signal transduction.
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